Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

Eur J Haematol. 2009 Mar;82(3):240-1. doi: 10.1111/j.1600-0609.2008.01184.x. Epub 2008 Nov 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / drug therapy*
  • Nitrosourea Compounds / adverse effects*
  • Nitrosourea Compounds / therapeutic use*
  • Organophosphorus Compounds / adverse effects*
  • Organophosphorus Compounds / therapeutic use*
  • Recurrence

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine